Trodelvy Now! Latest Update
METUPUK are delighted that NICE has accepted Trodelvy (sacituzumab govitecan) for routine use on the NHS in England for the treatment of patients with unresectable locally advanced or metastatic…
Read more
Treatment Options news
Articles filed under Treatment Options.
Articles
Improving access to new breast cancer drugs
When I first started volunteering with METUPUK, I wasn’t really sure what I would do. For a few months, I sat on the sides to get a feel for the organisation. I shared METUPUK links on social media,…
Read more
Why we need MBC research more than ever
At METUPUK, we dream of the day when metastatic breast cancer (MBC) is downgraded from an incurable to a chronic illness. The only way this will be possible is through new scientific research. We…
Read more
Trodelvy is approved by the Scottish Medicines Consortium (SMC) for Metastatic Triple Negative Breast Cancer for use by NHS Scotland
*METUPUK welcomes the Scottish Medicines Consortium (SMC) acceptance of Trodelvy® (sacituzumab govitecan) for use within NHSScotland.* Trodelvy is an innovative drug which has been accepted for the…
Read more
Tucatinib is approved by NICE for HER2+ metastatic breast cancer
METUPUK welcome the National Institute of Clinical Excellence (NICE) decision to accept Tucatinib with trastuzumab and capecitabine for treating HER2-positive unresectable locally advanced or…
Read more
METUPUK are delighted by the Scottish Medicines Consortium (SMC) approval of two new drugs for metastatic breast cancer for use by NHS Scotland
The Scottish Medicines Consortium (SMC) has approved today: Trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer in adults who have received two or…
Read more
A #TrodelvyNow Update
Following on from our #TrodelvyNow post last month, MetUpUk Member Phillippa has appeared in the Daily Mail, alongside other women for who this drug could mean, literally the difference between life…
Read more
#TrodelvyNow!
Of all the subtypes of metastatic breast cancer, metastatic Triple Negative Breast Cancer (TNBC) is the hardest to treat with the worst prognosis. While new advances in the treatment of hormone…
Read more
Friends and family friday – Connie and her friends
MetUpUK member Connie sat down, on zoom, with some of her oldest friends to talk to them about their understanding of her life with MBC. They discuss cancer types, treatment lines, tumor profiling,…
Read more
Fighting for Palbociclib
Under NICE rules, I would not be eligible to receive the medication that I am currently taking for my metastatic breast cancer on the NHS. I have been on my current drug regime since 2017, I am…
Read more
The Cancer Postcode Lottery
I have been living with secondary breast cancer for 7 years, and am very aware that I’m one of the very lucky ones as the median life expectancy is 2-3 years. The general public perception of breast…
Read more
Aren’t you a bit young to have a pacemaker
Stage 4 breast cancer with a pacemaker Most people know someone with a pacemaker, and chances are that person will be elderly. The average age of a first pacemaker implantation in the UK is 72, but…
Read more